
Emergency news
All →Our emergency work in focus
All →
Publications
All →Therapeutics and COVID-19: living guideline, August 2025
The WHO Therapeutics and COVID-19: living guideline contains recommendations for the use of therapeutics in the treatment of COVID-19. It is...
The COVID-19 Clinical management: living guidance contains the most up-to-date WHO recommendations for the clinical management of people with COVID-19....
NAPHS for all: a country implementation guide for national action plan for health security (NAPHS)
A national action plan for health security (NAPHS) is a country-owned, multi-year, joint planning process that can improve the implementation of IHR core...

Clinical practice guidelines for influenza
This WHO Clinical practice guideline for influenza is an update and expansion from the previously published WHO guideline on the clinical management of...
Documents
All →
60-day ceasefire plan for Gaza
With the initiation of the first phase of the ceasefire in Gaza, humanitarian needs remain dire. In the current situation, it is crucial to scale up humanitarian...
f52c15d2-e394-4998-a5f6-112d0ec915ce.tmb-144v.png?sfvrsn=6c4a737_1)
WHO Rapid Risk Assessment - Mpox, Global v.5
This Rapid Risk Assessment (RRA) aims to assess the risk of mpox at the global level, considering the public health impact, the risk of geographical spread...

WHO Rapid Risk Assessment - Cholera, Global v.6
This Rapid Risk Assessment (RRA) aims to assess the risk of cholera at the global level, considering the public health impact, the risk of geographical...

Multi-country outbreak of cholera, external situation report #30 -26 September 2025
From 1 January to 31 August 2025, a cumulative total of 462 890 cholera cases and 5869 deaths were reported from 32 countries across five WHO regions,...
More about our work in emergencies
Tracking SARS-CoV-2 variants
Overview
All viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus’s properties. However, some changes may affect the virus’s properties, such as how easily it spreads, the associated disease severity, or the performance of vaccines, therapeutic medicines, diagnostic tools, or other public health and social measures.
In June 2020, the WHO Virus Evolution Working Group was established with a specific focus on SARS-CoV-2 variants, their phenotype and their impact on countermeasures. This later became the Technical Advisory Group on SARS-CoV-2 Virus Evolution. In late 2020, the emergence of variants that posed an increased risk to global public health prompted WHO to characterize some as variants of interest (VOIs) and variants of concern (VOCs) in order to prioritize global monitoring and research, and to inform and adjust the COVID-19 response. From May 2021 onwards, WHO began assigning simple, easy-to-say labels for key variants.
Considerable progress has been made in establishing and strengthening a global system to detect signals of potential VOIs or VOCs and rapidly assess the risk posed by SARS-CoV-2 variants to public health. More specifically, in 2024 WHO launched a WHO Coronavirus Network (CoViNet) to facilitate early and accurate detection of coronaviruses and variant tracking including coordinating risk evaluations. It remains critical that these systems are maintained, and data are shared, according to good principles and in a timely fashion, as SARS-CoV-2 continues to circulate at high levels around the world. While monitoring the circulation of SARS-CoV-2 globally, it also remains essential to monitor their spread in animal populations and chronically infected individuals, which are crucial aspects of the global strategy to reduce the occurrence of mutations that have negative public health implications. In March 2023, WHO updated its tracking system and working definitions for variants of concern, variants of interest and variants under monitoring. They can be found here. The previous working definitions can be found here.